|
Volumn 64, Issue 7, 2000, Pages 415-417
|
Optimizing the bioavailability of itraconazole
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTICONVULSIVE AGENT;
ANTIMYCOBACTERIAL AGENT;
BENZODIAZEPINE;
BUSULFAN;
CALCIUM CHANNEL BLOCKING AGENT;
CARBAMAZEPINE;
CLARITHROMYCIN;
DIGOXIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
INDINAVIR;
ISONIAZID;
ITRACONAZOLE;
NEVIRAPINE;
OMEPRAZOLE;
PHENOBARBITAL;
PHENYTOIN;
PROTEINASE INHIBITOR;
PROTON PUMP INHIBITOR;
QUINIDINE;
RANITIDINE;
RIFABUTIN;
RIFAMPICIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SUCRALFATE;
UNINDEXED DRUG;
VINCA ALKALOID;
AREA UNDER THE CURVE;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG COMPETITION;
DRUG FORMULATION;
FOOD DRUG INTERACTION;
HUMAN;
SHORT SURVEY;
STOMACH SECRETION;
ANTIFUNGAL AGENTS;
BIOLOGICAL AVAILABILITY;
CAPSULES;
DRUG INTERACTIONS;
HUMANS;
ITRACONAZOLE;
SOLUTIONS;
|
EID: 0033863742
PISSN: 00106178
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (5)
|
References (6)
|